Src Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment

• Sarah L. Larsen,

  Affiliation Breast Cancer Group, Cell Death and Metabolism, Danish Cancer Society Research Center, Copenhagen, Denmark

  ⨯
• Anne-Vibeke Laenkholm,

  Affiliation Department of Pathology, Slagelse Hospital, Slagelse, Denmark

  ⨯
• Anne Katrine Duun-Henriksen,

  Affiliation Statistics, Bioinformatics and Registry, Danish Cancer Society Research Center, Copenhagen, Denmark

  ⨯
• Martin Bak,

  Affiliation Department of Pathology, Odense University Hospital, Odense, Denmark

  ⨯
• Anne E. Lykkesfeldt,

  Affiliation Breast Cancer Group, Cell Death and Metabolism, Danish Cancer Society Research Center, Copenhagen, Denmark

  ⨯
• Tove Kirkegaard

  * E-mail: tki@cancer.dk

  Affiliation Breast Cancer Group, Cell Death and Metabolism, Danish Cancer Society Research Center, Copenhagen, Denmark

  ⨯